Hologic Shareholders Approve Blackstone and TPG Buyout Deal

The latest announcement is out from Hologic ( (HOLX) ).

On February 5, 2026, Hologic held a special meeting of stockholders to vote on the proposed acquisition of the company by affiliates of funds managed by Blackstone Inc. and TPG Global, LLC. Stockholders representing about 80% of outstanding shares participated, and an overwhelming majority approved the Agreement and Plan of Merger dated October 21, 2025, effectively clearing a key shareholder hurdle for the buyout, while a separate, non-binding advisory proposal on executive compensation related to the merger was voted down; the merger is expected to close in March or April 2026, subject to regulatory approvals and customary conditions.

The most recent analyst rating on (HOLX) stock is a Buy with a $85.00 price target. To see the full list of analyst forecasts on Hologic stock, see the HOLX Stock Forecast page.

Spark’s Take on HOLX Stock

According to Spark, TipRanks’ AI Analyst, HOLX is a Neutral.

The score is supported primarily by strong free cash flow generation and a stable balance sheet, but is held back by the sharp TTM revenue decline and margin compression. Valuation appears less attractive at ~30x earnings given the recent fundamental pressure, while technicals are broadly neutral. Corporate-event risks (merger-related litigation and product recall impact) further weigh on the outlook.

To see Spark’s full report on HOLX stock, click here.

More about Hologic

Hologic, Inc. operates in the medical technology and diagnostics industry, focusing on specialized products and services such as diagnostic and medical imaging solutions with a significant footprint in women’s health and related healthcare markets.

Average Trading Volume: 2,836,599

Technical Sentiment Signal: Buy

Current Market Cap: $16.65B

For an in-depth examination of HOLX stock, go to TipRanks’ Overview page.